4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000069
Chief Executive Officer sold 44,034 shares at $74.82 ($3,294,624)
- Chief Executive Officer acquired 89,145 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Monia Brett P · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-15 | Exercise or conversion : show line 1 in the form | +89,145 | 268,717 | D | ||
| 2026-01-16 | Sale : show line 2 in the form | −44,034 | $74.82 | $3,294,624 | 224,683 | D |
| Open-market sales · 44,034 sh · avg $74.82 · $3,294,624 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-15 | Grant or award : show line 3 in the form Performance Restricted Stock Units | +113,880 | 744,081 | D |
| 2026-01-15 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −89,145 | 163,014 | D |
| 2026-01-15 | Grant or award : show line 5 in the form Restricted Stock Unit | +42,705 | 205,719 | D |
Loading xslF345X05/edgardoc.xml…